Lithium Carbonate Tablet, Film Coated, Extended Release
Product Images NDC 68462-223

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 68462-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lbl300mg100s

Lbl300mg100s
This is a prescription medication with the active ingredient Lithium Carbonate. It is in the form of extended-release tablets, and there are 100 tablets in the package. The manufacturer is Glenmark. No prescribing information is provided.*
FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.